efficacy of semaglutide and safety once-weekly monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial sustain 6 trial Efficacy and Safety of Once-Weekly

We wrote more about the science of how GLP-1 works in weight loss, here: GLP-1 for Weight Loss

Create your account and start earning from your very first order

Participants in the trial who used tirzepatide had better improved A1C, lost more weight, and had less instances of hypoglycemia than those who used fast-acting insulin.

Related products and categories can help you identify nearby choices, but treatment decisions should remain under appropriate medical supervision

There's no universal 'best' here, just the 'best for your specific inquiry.' We encourage researchers to meticulously evaluate their project's unique requirements, consult with our expert team, and carefully consider the pharmacokinetic implications of each route

Provider-Administered Medications: Crucially, many drugs given by infusion, injection, or on-site administration are paid as part of the medical benefit